tTMB-P3(12.41) Reference Standard

CBP80001-3

询价

索取COA

产品描述

产品数据库

I. Background

Tumor mutational burden (TMB) shows great promise as a biomarker for immuno-oncology (I-O) therapy response, but progress is hindered by the lack of a standardized TMB measurement by targeted NGS panels, and an absence of TMB reference materials.

Sample ID	Cat.No.	Background	Assay	Comments
DC198N0161	CBP80001-3N	B lymphoblast, Female	500x WES	Same individual
DC198N0160	CBP80001-3T	Ductal breast carcinoma, Female	500x WES	Same individual
IDT xGenExome Research Panel v1.0捕获，Target Region 39M, Probe Region 51M，CDS Region 33.52M; HiSeq X-TEN，af选择0.02 cut off，再过滤。 DC198N0160 is 100% Tumor sample.

	Cut off =2%	Cut off =3%	Cut off =4%	Cut off =5%
Mutation Number	416	398	386	383
TMB value	12.41	11.87	11.52	11.43

计算数据下载：DC198N0160.tmb

相关产品推荐

• bTMB-P1 (22.91) Reference Standard • TMB Reference Standard • tTMB-P1(5.37) Reference Standard • tTMB-P2(9.84) Reference Standard • tTMB-P4(21.09) Reference Standard • tTMB-P5(27.15) Reference Standard • tTMB-P6(8.98) Reference Standard • tTMB-P7(6.83) Reference Standard • tTMB-P8(27.15) Reference Standard • tTMB-P9(matrix) Reference Standard

上一篇：tTMB-P2(9.84) Reference Standard

下一篇：tTMB-P4(21.09) Reference Standard

返回列表